01
Many men engage late with prostate health
Make suitability and screening information easier to understand before symptoms drive action.
The healthcare opportunity
Earlier risk conversations need a responsible pathway.
The opportunity is not simply to make another test available. It is to connect understandable screening, dependable operations, and appropriate clinical follow-up around the patient.
PatientDoctorLaboratoryNetwork
Need and response
Access matters. So does everything surrounding it.
These are system-level challenges and proposed design responses. They should not be read as evidence that SeroMark-1 improves outcomes or has completed every required validation step.
Healthcare needResponsible response
02
Access varies by geography and care setting
Develop assessed collection and clinical routes through appropriate local partners.
03
A result can be misunderstood without context
Keep doctor interpretation, limitations, and next-step guidance inside the reporting pathway.
04
Scale can weaken quality if governance lags
Tie expansion to traceability, training, oversight, evidence, and quality requirements.
A responsible scale pathway
Progress in stages, with evidence at each gate.
Expansion should remain conditional on evidence, regulatory alignment, partner readiness, service quality, and patient safety.
Validate
Define intended use, evaluate performance, document limitations, and align claims with evidence and regulation.
Establish
Prepare clinical, collection, laboratory, reporting, training, security, and support workflows.
Learn
Monitor quality, patient experience, adoption, service issues, and real-world operating performance.
Expand
Add access only where capabilities, oversight, and appropriate local partnerships are ready.
The standard that matters
Four questions every stakeholder should be able to answer.
Responsible innovation is easier to trust when expectations are explicit and gaps are acknowledged early.
- 01
Can patients understand what the test can and cannot tell them?
- 02
Can doctors interpret the result within an appropriate care pathway?
- 03
Can every sample be identified, handled, tracked, and reported responsibly?
- 04
Can the service explain its evidence, limitations, governance, and escalation routes?
Work with Nutech
Help shape a clinically responsible access model.
We welcome relevant perspectives from healthcare organizations, researchers, laboratories, doctors, and strategic stakeholders.